Production of bacteriocins in a liquid medium by Streptococcus mutans.

Antimicrobial Agents and Chemotherapy
A L Delisle

Abstract

A sterile-filtered, liquid medium composed of one-half-strength APT broth and 4% (wt/vol) yeast extract was found to support the production of bacteriocins by Streptococcus mutans strains BHT and GS-5. Culture supernatants, adjusted to pH 7.0 and sterilized by filtration, contained bacteriocin-like activity, which could be demonstrated by spotting dilutions onto top agar lawns seeded with Streptococcus pyogenes as the sensitive indicator and by adding dilutions to log-phase indicator broth cultures. A quantitative assay was developed for BHT bacteriocin, based on its lethal effects. Bacteriocin production did not occur until after the log phase of growth had ceased and was not inducible by ultraviolet irradiation or treatment with mitomycin C. Non-bacteriocinogenic clones of strain BHT occurred spontaneously at high frequency, suggesting control by a plasmid, but this frequency was not increased by treatment with the plasmid-curing agents acridine orange and ethidium bromide.

References

Jun 1, 1969·Bacteriological Reviews·R P Novick
Mar 1, 1969·Archives of Oral Biology·J Kelstrup, R J Gibbons
Apr 1, 1966·Archives of Oral Biology·B Krasse
Jan 1, 1968·Caries Research·B Guggenheim
Jan 1, 1970·Caries Research·J Carlsson
Dec 1, 1970·Archives of Oral Biology·J KelstrupR J Gibbons
Jan 1, 1969·Antonie van Leeuwenhoek·F K de GraafA H Stouthamer
Jul 1, 1960·The Journal of the American Dental Association·R J FITZGERALD, P H KEYES
Mar 1, 1965·Proceedings of the Society for Experimental Biology and Medicine·D D ZINNERM S SASLAW

❮ Previous
Next ❯

Citations

Jul 10, 2008·International Journal of Antimicrobial Agents·M L ChikindasJ R Tagg
Apr 1, 1991·The Journal of Applied Bacteriology·S E TzannetisJ Papavassiliou
Mar 8, 2012·Molecular Oral Microbiology·J Merritt, F Qi
Sep 1, 1977·Antimicrobial Agents and Chemotherapy·C K FrankerS Ueda
Dec 1, 1978·Antimicrobial Agents and Chemotherapy·S Fujimura, T Nakamura
May 1, 1980·Antimicrobial Agents and Chemotherapy·J M BallesterJ P Belaich
Jan 1, 1980·Archives of Oral Biology·H FukushimaH Sagawa
Jun 1, 1983·The Science of the Total Environment·S N Luoma
Nov 27, 2002·Journal of Medical Microbiology·M BalakrishnanJ R Tagg
Jul 1, 1977·Infection and Immunity·F L MacrinaD J Kopecko
Jun 1, 1980·Microbiological Reviews·S Hamada, H D Slade

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.